ArticleCureus2026
Lymphoma or Hematoma: Emergency Department Recognition of a Diagnostic Pitfall.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neck swelling with upper-extremity edema in a cancer patient presenting to the emergency department (ED) is a concerning clinical picture that may indicate underlying venous obstruction or malignancy. A 74-year-old woman developed a rapidly enlarging left supraclavicular mass after core needle biopsy of a lesion later diagnosed as high-grade follicular large B-cell lymphoma. Follow-up imaging initially suggested a postprocedural hematoma; however, bedside Doppler ultrasound in the emergency department demonstrated internal vascular flow, prompting repeat contrast-enhanced computed tomography (CT), which confirmed aggressive tumor progression with venous compression rather than bleeding. The patient was admitted for emergent inpatient Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) chemotherapy, which resulted in rapid symptomatic improvement and complete metabolic remission. This case highlights the diagnostic ambiguity of rapid postbiopsy enlargement of malignant neck masses and underscores the importance of bedside ultrasound, multidisciplinary evaluation, and reconsideration of initial imaging interpretations to avoid delays in definitive therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.